Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences

PURPOSE: Sensitive methods for risk stratification, monitoring therapeutic efficacy, and early relapse detection may have a major impact on treatment decisions and patient management for stage III colorectal cancer patients. Beyond assessing the predictive power of postoperative ctDNA detection, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Henriksen, Tenna Vesterman, Tarazona, Noelia, Frydendahl, Amanda, Reinert, Thomas, Gimeno-Valiente, Francisco, Carbonell-Asins, Juan Antonio, Sharma, Shruti, Renner, Derrick, Hafez, Dina, Roda, Desamparados, Huerta, Marisol, Roselló, Susana, Madsen, Anders Husted, Løve, Uffe S., Andersen, Per Vadgaard, Thorlacius-Ussing, Ole, Iversen, Lene Hjerrild, Gotschalck, Kåre Andersson, Sethi, Himanshu, Aleshin, Alexey, Cervantes, Andres, Andersen, Claus Lindbjerg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Precision Medicine and Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401484/
https://www.ncbi.nlm.nih.gov/pubmed/34625408
http://dx.doi.org/10.1158/1078-0432.CCR-21-2404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401484/
https://www.ncbi.nlm.nih.gov/pubmed/34625408
http://dx.doi.org/10.1158/1078-0432.CCR-21-2404

Ejemplares similares